JISTALYX Trademark

Trademark Overview

On Wednesday, November 13, 2019, a trademark application was filed for JISTALYX with the United States Patent and Trademark Office. The USPTO has given the JISTALYX trademark a serial number of 88690805. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 26, 2020. This trademark is owned by Glaxo Group Limited. The JISTALYX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jistalyx

General Information

Serial Number88690805
Word MarkJISTALYX
Filing DateWednesday, November 13, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 26, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Wednesday, August 26, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, August 26, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 13, 2020NON-FINAL ACTION E-MAILED
Thursday, February 13, 2020NON-FINAL ACTION WRITTEN
Wednesday, February 12, 2020ASSIGNED TO EXAMINER
Wednesday, November 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 16, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

jistalyx pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological